NEUROBO PHARMACEUTICALS INC (NRBO) Forecast, Price Target & Analyst Ratings

NASDAQ:NRBO • US64132R4048

Current stock price

2.36 USD
+0.01 (+0.43%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NEUROBO PHARMACEUTICALS INC (NRBO).

Forecast Snapshot

Consensus Price Target

Price Target
$27.20
+ 1,052.54% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q4 / 2024
EPS Estimate
-$0.67
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$27.20
Upside
+ 1,052.54%
From current price of $2.36 to mean target of $27.20, Based on 8 analyst forecasts
Low
$10.10
Median
$22.44
High
$50.40

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for NRBO. The average price target is 27.2 USD. This implies a price increase of 1052.54% is expected in the next year compared to the current price of 2.36.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

NRBO Current Analyst RatingNRBO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

NRBO Historical Analyst RatingsNRBO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
85.00%
NRBO was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about NRBO.
In the previous month the buy percentage consensus was at a similar level.
NRBO was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-05-08Maxim GroupInitiate Buy
2022-12-07Ladenburg ThalmannInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q4 / 2024
EPS Estimate
-$0.67
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
70.77%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
27.00%
EPS (3 Months)
26.04%

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2024 - 2026

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
NRBO revenue by date.NRBO revenue by date.
N/AN/AN/A
EBITDA
YoY % growth
NRBO ebitda by date.NRBO ebitda by date.
N/AN/AN/A-22.81M-8M
64.93%		-12.33M
-54.12%		-15.25M
-23.68%		-11.4M
25.25%		-15.88M
-39.30%		N/AN/AN/A
EBIT
YoY % growth
NRBO ebit by date.NRBO ebit by date.
-7.16M-14.7M
-105.31%		-33.12M
-125.31%		-22.81M
31.13%		-8.02M
64.84%		-12.38M
-54.36%		-15.3M
-23.59%		-11.42M
25.36%		-15.886M
-39.11%		N/A
-99.62%		N/A
15.35%		N/A
-12.90%
Operating Margin
NRBO operating margin by date.NRBO operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
NRBO eps by date.NRBO eps by date.
N/AN/A-2,242.50
-47.31%		-1,305.00
41.81%		N/A
79.37%		-55.20
79.50%		N/AN/A-3.93
95.84%		N/A
-4.04%		N/A
61.06%		N/A
9.92%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.67
70.77%		-0.60
54.29%		-0.36
80.70%		-0.37
33.24%		-0.41
37.93%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-8.031M
-41.72%		-8.088M
-17.54%		-6.777M
32.79%		-7.049M
-12.62%		-7.796M
2.93%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

NRBO Yearly EPS VS EstimatesNRBO Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2022 2023 2024 2025 2026 -500 -1K -1.5K -2K -2.5K

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
17.81%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

NEUROBO PHARMACEUTICALS INC / NRBO Forecast FAQ

What do analysts expect the price target to be for NEUROBO PHARMACEUTICALS INC (NRBO)?

8 analysts have analysed NRBO and the average price target is 27.2 USD. This implies a price increase of 1052.54% is expected in the next year compared to the current price of 2.36.

What are the consensus estimates for NEUROBO PHARMACEUTICALS INC (NRBO) next earnings?

The consensus EPS estimate for the next earnings of NEUROBO PHARMACEUTICALS INC (NRBO) is -0.67 USD and the consensus revenue estimate is 0 USD.

What is the consensus rating for NRBO stock?

The consensus rating for NEUROBO PHARMACEUTICALS INC (NRBO) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.